vs
Side-by-side financial comparison of Carlyle Group Inc. (CG) and Organon & Co. (OGN). Click either name above to swap in a different company.
Carlyle Group Inc. is the larger business by last-quarter revenue ($1.9B vs $1.5B, roughly 1.3× Organon & Co.). Carlyle Group Inc. runs the higher net margin — 18.8% vs -13.6%, a 32.4% gap on every dollar of revenue. On growth, Carlyle Group Inc. posted the faster year-over-year revenue change (84.1% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $-1.2B). Over the past eight quarters, Carlyle Group Inc.'s revenue compounded faster (66.2% CAGR vs -3.6%).
The Carlyle Group Inc. is an American multinational company with operations in private equity, alternative asset management and financial services. As of 2023, the company had $426 billion of assets under management.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
CG vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.9B | $1.5B |
| Net Profit | $358.1M | $-205.0M |
| Gross Margin | — | 49.2% |
| Operating Margin | 24.3% | -9.8% |
| Net Margin | 18.8% | -13.6% |
| Revenue YoY | 84.1% | -5.3% |
| Net Profit YoY | 69.8% | -288.1% |
| EPS (diluted) | $0.96 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.9B | $1.5B | ||
| Q3 25 | $332.7M | $1.6B | ||
| Q2 25 | $1.6B | $1.6B | ||
| Q1 25 | $973.1M | $1.5B | ||
| Q4 24 | $1.0B | $1.6B | ||
| Q3 24 | $2.6B | $1.6B | ||
| Q2 24 | $1.1B | $1.6B | ||
| Q1 24 | $688.4M | $1.6B |
| Q4 25 | $358.1M | $-205.0M | ||
| Q3 25 | $900.0K | $160.0M | ||
| Q2 25 | $319.7M | $145.0M | ||
| Q1 25 | $130.0M | $87.0M | ||
| Q4 24 | $210.9M | $109.0M | ||
| Q3 24 | $595.7M | $359.0M | ||
| Q2 24 | $148.2M | $195.0M | ||
| Q1 24 | $65.6M | $201.0M |
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 54.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | — | 58.3% | ||
| Q2 24 | — | 58.4% | ||
| Q1 24 | — | 59.0% |
| Q4 25 | 24.3% | -9.8% | ||
| Q3 25 | 25.8% | 15.2% | ||
| Q2 25 | 28.0% | 14.4% | ||
| Q1 25 | 17.6% | 6.7% | ||
| Q4 24 | 25.7% | 8.1% | ||
| Q3 24 | 29.9% | 13.1% | ||
| Q2 24 | 20.5% | 14.6% | ||
| Q1 24 | 17.5% | 14.5% |
| Q4 25 | 18.8% | -13.6% | ||
| Q3 25 | 0.3% | 10.0% | ||
| Q2 25 | 20.3% | 9.1% | ||
| Q1 25 | 13.4% | 5.8% | ||
| Q4 24 | 20.4% | 6.8% | ||
| Q3 24 | 22.6% | 22.7% | ||
| Q2 24 | 13.9% | 12.1% | ||
| Q1 24 | 9.5% | 12.4% |
| Q4 25 | $0.96 | $-0.78 | ||
| Q3 25 | $0.00 | $0.61 | ||
| Q2 25 | $0.87 | $0.56 | ||
| Q1 25 | $0.35 | $0.33 | ||
| Q4 24 | $0.56 | $0.42 | ||
| Q3 24 | $1.63 | $1.38 | ||
| Q2 24 | $0.40 | $0.75 | ||
| Q1 24 | $0.18 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.0B | $574.0M |
| Total DebtLower is stronger | — | $8.6B |
| Stockholders' EquityBook value | $7.1B | $752.0M |
| Total Assets | $29.1B | $12.9B |
| Debt / EquityLower = less leverage | — | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.0B | $574.0M | ||
| Q3 25 | $2.2B | $672.0M | ||
| Q2 25 | $1.3B | $599.0M | ||
| Q1 25 | $1.2B | $547.0M | ||
| Q4 24 | $1.3B | $675.0M | ||
| Q3 24 | $1.4B | $763.0M | ||
| Q2 24 | $914.8M | $704.0M | ||
| Q1 24 | $1.3B | $575.0M |
| Q4 25 | — | $8.6B | ||
| Q3 25 | — | $8.8B | ||
| Q2 25 | — | $8.9B | ||
| Q1 25 | — | $9.0B | ||
| Q4 24 | — | $8.9B | ||
| Q3 24 | — | $8.7B | ||
| Q2 24 | — | $8.7B | ||
| Q1 24 | — | $8.7B |
| Q4 25 | $7.1B | $752.0M | ||
| Q3 25 | $6.8B | $906.0M | ||
| Q2 25 | $6.7B | $733.0M | ||
| Q1 25 | $6.4B | $542.0M | ||
| Q4 24 | $6.3B | $472.0M | ||
| Q3 24 | $6.3B | $493.0M | ||
| Q2 24 | $5.7B | $144.0M | ||
| Q1 24 | $5.7B | $48.0M |
| Q4 25 | $29.1B | $12.9B | ||
| Q3 25 | $27.1B | $13.6B | ||
| Q2 25 | $25.1B | $13.5B | ||
| Q1 25 | $24.1B | $13.2B | ||
| Q4 24 | $23.1B | $13.1B | ||
| Q3 24 | $22.7B | $12.8B | ||
| Q2 24 | $22.3B | $12.2B | ||
| Q1 24 | $20.8B | $11.9B |
| Q4 25 | — | 11.49× | ||
| Q3 25 | — | 9.74× | ||
| Q2 25 | — | 12.14× | ||
| Q1 25 | — | 16.52× | ||
| Q4 24 | — | 18.81× | ||
| Q3 24 | — | 17.75× | ||
| Q2 24 | — | 60.11× | ||
| Q1 24 | — | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2B | $141.0M |
| Free Cash FlowOCF − Capex | $-1.2B | $96.0M |
| FCF MarginFCF / Revenue | -65.1% | 6.4% |
| Capex IntensityCapex / Revenue | 2.2% | 3.0% |
| Cash ConversionOCF / Net Profit | -3.34× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-3.4B | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.2B | $141.0M | ||
| Q3 25 | $-1.6B | $264.0M | ||
| Q2 25 | $-168.8M | $220.0M | ||
| Q1 25 | $-352.1M | $75.0M | ||
| Q4 24 | $-352.8M | $390.0M | ||
| Q3 24 | $791.9M | $141.0M | ||
| Q2 24 | $-1.3B | $332.0M | ||
| Q1 24 | $71.1M | $76.0M |
| Q4 25 | $-1.2B | $96.0M | ||
| Q3 25 | $-1.6B | $218.0M | ||
| Q2 25 | $-186.3M | $181.0M | ||
| Q1 25 | $-368.8M | $43.0M | ||
| Q4 24 | $-379.5M | $335.0M | ||
| Q3 24 | $772.8M | $99.0M | ||
| Q2 24 | $-1.3B | $300.0M | ||
| Q1 24 | $56.9M | $30.0M |
| Q4 25 | -65.1% | 6.4% | ||
| Q3 25 | -475.7% | 13.6% | ||
| Q2 25 | -11.8% | 11.4% | ||
| Q1 25 | -37.9% | 2.8% | ||
| Q4 24 | -36.8% | 21.0% | ||
| Q3 24 | 29.3% | 6.3% | ||
| Q2 24 | -120.4% | 18.7% | ||
| Q1 24 | 8.3% | 1.8% |
| Q4 25 | 2.2% | 3.0% | ||
| Q3 25 | 7.0% | 2.9% | ||
| Q2 25 | 1.1% | 2.4% | ||
| Q1 25 | 1.7% | 2.1% | ||
| Q4 24 | 2.6% | 3.5% | ||
| Q3 24 | 0.7% | 2.7% | ||
| Q2 24 | 1.7% | 2.0% | ||
| Q1 24 | 2.1% | 2.8% |
| Q4 25 | -3.34× | — | ||
| Q3 25 | -1732.78× | 1.65× | ||
| Q2 25 | -0.53× | 1.52× | ||
| Q1 25 | -2.71× | 0.86× | ||
| Q4 24 | -1.67× | 3.58× | ||
| Q3 24 | 1.33× | 0.39× | ||
| Q2 24 | -8.57× | 1.70× | ||
| Q1 24 | 1.08× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CG
| Fund Management Fee | $606.8M | 32% |
| Other | $528.7M | 28% |
| Global Private Equity Segment | $307.3M | 16% |
| Global Credit Segment | $238.0M | 13% |
| Carlyle Alp Invest Segment | $124.6M | 7% |
| Incentive Fee | $55.4M | 3% |
| Fee Related Performance Revenues | $29.2M | 2% |
| Investment Advice | $11.1M | 1% |
OGN
Segment breakdown not available.
